Substance Abuse — fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults
Citation(s)
Brewer JA, Potenza MN The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol. 2008 Jan 1;75(1):63-75. Epub 2007 Jul 3. Review.
Brewin CR, Dalgleish T, Joseph S A dual representation theory of posttraumatic stress disorder. Psychol Rev. 1996 Oct;103(4):670-86. Review.
Brewin CR A cognitive neuroscience account of posttraumatic stress disorder and its treatment. Behav Res Ther. 2001 Apr;39(4):373-93. Review.
Charney DS Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry. 2004 Feb;161(2):195-216. Review.
Chee MW, Sriram N, Soon CS, Lee KM Dorsolateral prefrontal cortex and the implicit association of concepts and attributes. Neuroreport. 2000 Jan 17;11(1):135-40.
Coffey SF, Stasiewicz PR, Hughes PM, Brimo ML Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35.
Fein G, Di Sclafani V, Meyerhoff DJ Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend. 2002 Sep 1;68(1):87-93.
Goldin PR, McRae K, Ramel W, Gross JJ The neural bases of emotion regulation: reappraisal and suppression of negative emotion. Biol Psychiatry. 2008 Mar 15;63(6):577-86. Epub 2007 Sep 21.
Goodman A Neurobiology of addiction. An integrative review. Biochem Pharmacol. 2008 Jan 1;75(1):266-322. Epub 2007 Jul 27. Review.
Houben K, Schoenmakers TM, Wiers RW I didn't feel like drinking but I don't know why: the effects of evaluative conditioning on alcohol-related attitudes, craving and behavior. Addict Behav. 2010 Dec;35(12):1161-3. doi: 10.1016/j.addbeh.2010.08.012. Epub 2010 Aug 11.
Koob GF The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction. 2006 Sep;101 Suppl 1:23-30. Review.
Matto H A bio-behavioral model of addiction treatment: applying dual representation theory to craving management and relapse prevention. Subst Use Misuse. 2005;40(4):529-41.
Matto HC, Strolin JS, Mogro-Wilson C A pilot study of a dual processing substance user treatment intervention with adults. Subst Use Misuse. 2008;43(3-4):285-94. doi: 10.1080/00952990701202848.
Matto HC, Strolin-Goltzman J Integrating social neuroscience and social work: innovations for advancing practice-based research. Soc Work. 2010 Apr;55(2):147-56. Review.
Phan KL, Wager T, Taylor SF, Liberzon I Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002 Jun;16(2):331-48.
Shaham Y, Erb S, Stewart J Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev. 2000 Aug;33(1):13-33. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
